Sectoral Asset Management as of June 30, 2019
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 92 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Shockwave Med (SWAV) | 5.8 | $49M | 850k | 57.09 | |
| Amicus Therapeutics (FOLD) | 5.0 | $42M | 3.3M | 12.48 | |
| Apellis Pharmaceuticals (APLS) | 4.5 | $38M | 1.5M | 25.34 | |
| Array BioPharma | 4.4 | $37M | 795k | 46.33 | |
| Teladoc (TDOC) | 4.1 | $34M | 513k | 66.41 | |
| Alnylam Pharmaceuticals (ALNY) | 3.5 | $29M | 403k | 72.56 | |
| Aerie Pharmaceuticals | 3.4 | $28M | 956k | 29.55 | |
| Gilead Sciences (GILD) | 3.2 | $27M | 398k | 67.56 | |
| Tandem Diabetes Care (TNDM) | 2.5 | $21M | 320k | 64.52 | |
| Ptc Therapeutics I (PTCT) | 2.4 | $20M | 451k | 45.00 | |
| Ra Pharmaceuticals | 2.4 | $20M | 666k | 30.07 | |
| Portola Pharmaceuticals | 2.3 | $20M | 722k | 27.13 | |
| Sarepta Therapeutics (SRPT) | 2.1 | $18M | 117k | 151.95 | |
| Novartis Sponsored Adr (NVS) | 2.0 | $17M | 183k | 91.31 | |
| Hill-Rom Holdings | 2.0 | $17M | 159k | 104.62 | |
| Pfizer (PFE) | 1.9 | $16M | 363k | 43.32 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.8 | $15M | 1.2M | 13.15 | |
| La Jolla Pharmaceuticl Com Par | 1.8 | $15M | 1.7M | 9.25 | |
| Wright Med Group N V Ord Shs | 1.8 | $15M | 511k | 29.82 | |
| Merck & Co (MRK) | 1.7 | $14M | 167k | 83.85 | |
| Fibrogen (FGEN) | 1.6 | $14M | 303k | 45.18 | |
| R1 Rcm | 1.6 | $14M | 1.1M | 12.58 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $13M | 153k | 85.65 | |
| Allergan SHS | 1.6 | $13M | 78k | 167.43 | |
| Vocera Communications | 1.5 | $12M | 382k | 31.92 | |
| Global Blood Therapeutics In | 1.4 | $12M | 226k | 52.60 | |
| Eli Lilly & Co. (LLY) | 1.4 | $12M | 107k | 110.79 | |
| AtriCure (ATRC) | 1.4 | $12M | 387k | 29.84 | |
| Assembly Biosciences | 1.4 | $11M | 848k | 13.49 | |
| Acceleron Pharma | 1.3 | $11M | 269k | 41.08 | |
| Evolent Health (EVH) | 1.3 | $11M | 1.4M | 7.95 | |
| D Stemline Therapeutics | 1.2 | $10M | 666k | 15.32 | |
| HMS Holdings | 1.2 | $10M | 311k | 32.39 | |
| Boston Scientific Corporation (BSX) | 1.2 | $9.7M | 227k | 42.98 | |
| Bristol Myers Squibb (BMY) | 1.2 | $9.7M | 215k | 45.35 | |
| Alexion Pharmaceuticals | 1.1 | $9.6M | 73k | 130.99 | |
| Viewray (VRAYQ) | 1.1 | $9.4M | 1.1M | 8.81 | |
| Albireo Pharma | 0.9 | $7.8M | 243k | 32.24 | |
| Medtronic SHS (MDT) | 0.9 | $7.5M | 77k | 97.40 | |
| Cigna Corp (CI) | 0.9 | $7.5M | 47k | 157.55 | |
| Inspire Med Sys (INSP) | 0.9 | $7.3M | 121k | 60.65 | |
| Obseva Sa | 0.9 | $7.3M | 643k | 11.31 | |
| Abbott Laboratories (ABT) | 0.8 | $7.0M | 83k | 84.10 | |
| Forty Seven | 0.8 | $7.0M | 657k | 10.60 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $6.9M | 38k | 183.37 | |
| Irhythm Technologies (IRTC) | 0.8 | $6.8M | 87k | 79.08 | |
| Glycomimetics (GLYC) | 0.8 | $6.6M | 553k | 11.92 | |
| Change Healthcare | 0.8 | $6.6M | 451k | 14.60 | |
| Meiragtx Holdings (MGTX) | 0.7 | $6.1M | 226k | 26.88 | |
| Evelo Biosciences | 0.7 | $6.0M | 669k | 8.98 | |
| Zimmer Holdings (ZBH) | 0.7 | $6.0M | 51k | 117.73 | |
| Immunomedics | 0.7 | $5.8M | 419k | 13.87 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $4.5M | 38k | 118.05 | |
| Tocagen | 0.5 | $4.5M | 670k | 6.68 | |
| Sage Therapeutics (SAGE) | 0.5 | $4.5M | 24k | 183.07 | |
| Insulet Corporation (PODD) | 0.5 | $4.3M | 36k | 119.39 | |
| Unum Therapeutics Ord | 0.5 | $4.2M | 1.6M | 2.62 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $4.0M | 80k | 49.88 | |
| Intec Pharma Ltd Jer SHS | 0.5 | $3.8M | 879k | 4.34 | |
| Molecular Templates | 0.3 | $2.9M | 350k | 8.35 | |
| Urogen Pharma (URGN) | 0.3 | $2.3M | 65k | 35.93 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.3 | $2.3M | 176k | 13.12 | |
| Savara (SVRA) | 0.2 | $1.8M | 741k | 2.37 | |
| Dr Reddys Labs Adr (RDY) | 0.2 | $1.5M | 39k | 37.46 | |
| Beigene Sponsored Adr (BGNE) | 0.2 | $1.4M | 11k | 123.99 | |
| Uniqure SHS (QURE) | 0.1 | $1.1M | 15k | 78.14 | |
| Blueprint Medicines (BPMC) | 0.1 | $1.0M | 11k | 94.32 | |
| Spring Bk Pharmaceuticals In | 0.1 | $1.0M | 277k | 3.69 | |
| Thermo Fisher Scientific (TMO) | 0.1 | $1.0M | 3.5k | 293.62 | |
| Becton, Dickinson and (BDX) | 0.1 | $760k | 3.0k | 252.07 | |
| Hutchison China Me Sponsored Adr (HCM) | 0.1 | $696k | 32k | 22.01 | |
| Zai Lab Adr (ZLAB) | 0.1 | $439k | 13k | 34.87 | |
| Abiomed | 0.1 | $424k | 1.6k | 260.76 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $389k | 18k | 22.16 | |
| Kura Oncology (KURA) | 0.0 | $232k | 12k | 19.66 | |
| Myokardia | 0.0 | $203k | 4.1k | 50.11 | |
| Acelrx Pharmaceuticals | 0.0 | $187k | 74k | 2.53 | |
| Chemocentryx | 0.0 | $166k | 18k | 9.32 | |
| Antares Pharma | 0.0 | $156k | 47k | 3.30 | |
| Revance Therapeutics (RVNC) | 0.0 | $146k | 11k | 13.00 | |
| Protagonist Therapeutics (PTGX) | 0.0 | $138k | 11k | 12.11 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $113k | 10k | 11.23 | |
| Mei Pharma | 0.0 | $111k | 45k | 2.49 | |
| Nabriva Therapeutics SHS | 0.0 | $93k | 38k | 2.43 | |
| Aeglea Biotherapeutics | 0.0 | $89k | 13k | 6.87 | |
| Marinus Pharmaceuticals | 0.0 | $70k | 17k | 4.17 | |
| Biolinerx Sponsored Ads | 0.0 | $65k | 178k | 0.36 | |
| Abeona Therapeutics | 0.0 | $61k | 13k | 4.81 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $47k | 13k | 3.73 | |
| Clearside Biomedical (CLSD) | 0.0 | $25k | 26k | 0.96 | |
| Sierra Oncology | 0.0 | $23k | 41k | 0.56 | |
| Tetraphase Pharmaceuticals | 0.0 | $19k | 40k | 0.48 |
